Search

Search Constraints

You searched for: Author/Creator Szilagyi, A

Search Results

2. A157 REAL-WORLD TIGHT OBJECTIVE MONITORING WITH ADALIMUMAB LEADS TO EARLIER DOSE OPTIMIZATION AND HIGHER CLINICAL REMISSION RATES AT 12 MONTHS. (4th March 2021)

7. P552 Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. (27th May 2021)